96 related articles for article (PubMed ID: 15136063)
21. Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients.
Shimazu T; Inami N; Satoh D; Kajiura T; Yamada K; Iwasaka T; Nomura S
J Thromb Thrombolysis; 2009 Nov; 28(4):429-35. PubMed ID: 19137265
[TBL] [Abstract][Full Text] [Related]
22. Significance of chemokines and activated platelets in patients with diabetes.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Fukuhara S
Clin Exp Immunol; 2000 Sep; 121(3):437-43. PubMed ID: 10971508
[TBL] [Abstract][Full Text] [Related]
23. [Effect of probucol on cardiac electrophysiology in anginal patients with hyperlipidemia and diabetes mellitus type II].
Anikin VV; Savin VV; Lupanov VP; Razygraev RA
Ter Arkh; 2000; 72(8):28-30. PubMed ID: 11019422
[TBL] [Abstract][Full Text] [Related]
24. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
25. Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus.
Nomura S; Omoto S; Yokoi T; Fujita S; Ozasa R; Eguchi N; Shouzu A
Int J Gen Med; 2011; 4():539-45. PubMed ID: 21845063
[TBL] [Abstract][Full Text] [Related]
26. Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T; Fukuhara S
Clin Appl Thromb Hemost; 2004 Jul; 10(3):205-15. PubMed ID: 15247977
[TBL] [Abstract][Full Text] [Related]
27. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?
Sener A; Ozsavci D; Oba R; Demirel GY; Uras F; Yardimci KT
Clin Biochem; 2005 Dec; 38(12):1081-7. PubMed ID: 16253220
[TBL] [Abstract][Full Text] [Related]
28. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
29. Serum lipid profile determines platelet reactivity to native and modified LDL-cholesterol in humans.
Katzman PL; Bose R; Henry S; McLean DL; Walker S; Fyfe C; Perry Y; Mymin D; Bolli P
Thromb Haemost; 1994 May; 71(5):627-32. PubMed ID: 8091392
[TBL] [Abstract][Full Text] [Related]
30. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
[TBL] [Abstract][Full Text] [Related]
31. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
32. Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome.
Matsumoto N; Nomura S; Kamihata H; Kimura Y; Iwasaka T
Thromb Haemost; 2004 Jan; 91(1):146-54. PubMed ID: 14691580
[TBL] [Abstract][Full Text] [Related]
33. Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Fukuhara S; Iwasaka T
Thromb Res; 2006; 117(4):385-92. PubMed ID: 15896827
[TBL] [Abstract][Full Text] [Related]
34. The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke.
Pawelczyk M; Baj Z; Chmielewski H; Kaczorowska B; Klimek A
Cerebrovasc Dis; 2009; 27(2):131-7. PubMed ID: 19047793
[TBL] [Abstract][Full Text] [Related]
35. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
36. Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel.
Gremmel T; Eslam RB; Koppensteiner R; Lang IM; Panzer S
Cardiovasc Ther; 2013 Oct; 31(5):e40-5. PubMed ID: 23311679
[TBL] [Abstract][Full Text] [Related]
37. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease.
Braun OO; Johnell M; Varenhorst C; James S; Brandt JT; Jakubowski JA; Winters KJ; Wallentin L; Erlinge D; Siegbahn A
Thromb Haemost; 2008 Oct; 100(4):626-33. PubMed ID: 18841285
[TBL] [Abstract][Full Text] [Related]
38. 5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
Blood Coagul Fibrinolysis; 2005 Sep; 16(6):423-8. PubMed ID: 16093733
[TBL] [Abstract][Full Text] [Related]
39. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy?
Bavbek N; Kargili A; Kaftan O; Karakurt F; Kosar A; Akcay A
Clin Appl Thromb Hemost; 2007 Oct; 13(4):391-7. PubMed ID: 17911190
[TBL] [Abstract][Full Text] [Related]
40. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]